TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems June 7, 1974
TCL Archive Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network. March 26, 2004
